GB2331460B - Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria - Google Patents

Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria

Info

Publication number
GB2331460B
GB2331460B GB9903338A GB9903338A GB2331460B GB 2331460 B GB2331460 B GB 2331460B GB 9903338 A GB9903338 A GB 9903338A GB 9903338 A GB9903338 A GB 9903338A GB 2331460 B GB2331460 B GB 2331460B
Authority
GB
United Kingdom
Prior art keywords
phyllanthus
hepatitis
extract
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9903338A
Other versions
GB9903338D0 (en
GB2331460A (en
Inventor
Tai Ho Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEPAGUARD CO Ltd
Original Assignee
HEPAGUARD CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEPAGUARD CO Ltd filed Critical HEPAGUARD CO Ltd
Publication of GB9903338D0 publication Critical patent/GB9903338D0/en
Publication of GB2331460A publication Critical patent/GB2331460A/en
Application granted granted Critical
Publication of GB2331460B publication Critical patent/GB2331460B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
GB9903338A 1996-08-16 1996-08-16 Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria Expired - Fee Related GB2331460B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR1996/000135 WO1998007437A1 (en) 1996-08-16 1996-08-16 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B COMPRISING EXTRACT OF PHYLLANTHUS USSURIENSIS AND/OR $i(PHYLLANTHUS URINARIA)

Publications (3)

Publication Number Publication Date
GB9903338D0 GB9903338D0 (en) 1999-04-07
GB2331460A GB2331460A (en) 1999-05-26
GB2331460B true GB2331460B (en) 1999-12-22

Family

ID=19449053

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9903338A Expired - Fee Related GB2331460B (en) 1996-08-16 1996-08-16 Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria

Country Status (3)

Country Link
JP (1) JP3249136B2 (en)
GB (1) GB2331460B (en)
WO (1) WO1998007437A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200100642T2 (en) 1998-08-25 2001-07-23 Yale University Prevention and treatment of helioxanthin and its analogs, hepatitis B virus and flavivirus.
WO2000027413A1 (en) * 1998-11-11 2000-05-18 Hepaguard Co., Ltd. Pharmaceutical composition for the treatment of hepatitis b comprising corilagin or brevifolin carboxylic acid
AU6013400A (en) * 2000-06-16 2001-12-24 Balakrishnan Arun Lignan compounds with antiproliferative properties
DE10120627A1 (en) * 2001-04-26 2002-10-31 Cmi Ag Use of phyllanthus components for the treatment or prophylaxis of infections caused by hepatitis B viruses
KR101559301B1 (en) 2014-02-25 2015-10-12 강원대학교산학협력단 A composition comprising the Phyllanthus urinaria extract and the compound isolated therefrom for preventing and treating enterovirus-or Coxsackievirus involved diseases
WO2019193381A1 (en) * 2018-04-05 2019-10-10 Thi Trieu NGUYEN Composition for treating hepatitis b

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199429A2 (en) * 1985-04-26 1986-10-29 Fox Chase Cancer Center Manufacture of a medicament for treating viral hepatitis
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199429A2 (en) * 1985-04-26 1986-10-29 Fox Chase Cancer Center Manufacture of a medicament for treating viral hepatitis
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same

Also Published As

Publication number Publication date
GB9903338D0 (en) 1999-04-07
GB2331460A (en) 1999-05-26
WO1998007437A1 (en) 1998-02-26
JP3249136B2 (en) 2002-01-21
JP2000511928A (en) 2000-09-12

Similar Documents

Publication Publication Date Title
IL119833A0 (en) Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
EP0958364A4 (en) Immunotherapy and improved vaccines
EP1112091A4 (en) Rapid cryobaric sterilization and vaccine preparation
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
IL127545A0 (en) Compositions and methods for administering borrelia DNA
EP0650370A4 (en) Methods and compositions for targeting specific tissue.
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
IL96915A0 (en) Method and apparatus for fragmentation of hard substances within the human body
HUP9700556A3 (en) Vaccine container with freeze-dried vaccine components and method for the preparation of such a vaccine container
PL332137A1 (en) Injectable preparations of avermerctins and milbemycins
EP0656791A4 (en) Therapeutic compositions and methods using pqq.
IL114119A0 (en) Compositions and methods for the treatment of tumors
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
EP0709420A3 (en) Block copolymer of polyesters and polycarbonates and process for the preparation thereof
GB2331460B (en) Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria
PL327853A1 (en) Materials and methods related to exodus chemokin
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
ZA9710934B (en) Compositions and methods for administering pneumococal dna
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
EP1018866A4 (en) Compositions and methods for the preservation of living tissues
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU1829097A (en) Methods for regenerating scarless skin and compositions used therein
AU4947700A (en) An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060816